1stOncology™: Cancer Intelligence Service – Page 13103 – 1stOncology is recognized as a Top 10 Global Pharma Analytic Provider

Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019

On April 30, 2019 Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, reported that first quarter 2019 financial results will be released on Thursday, May 2, 2019 before the market opens (Press release, Cambrex, APR 30, 2019, View Source [SID1234535466]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

The Company will host a conference call to discuss the financial results.

First Quarter 2019 Earnings Conference Call

When: Thursday, May 2, 2019 at 8:30 a.m. Eastern Time

Dial-in: 1-800-682-0995 for U.S.
1-334-323-0522 for International
Passcode: 2251796

Dial-in Replay: 1-888-203-1112 for U.S.
1-719-457-0820 for International
Passcode: 2251796
Available through Thursday, May 9, 2019

Webcast: www.cambrex.com

MannKind Corporation to Hold 2019 First Quarter Financial Results Conference Call on May 7, 2019

On April 30, 2019 MannKind Corporation (Nasdaq:MNKD) reported that it will release its 2019 first quarter financial results on Tuesday, May 7, 2019 and its management will host a conference call to discuss the financial results and other Company developments at 9:00 AM (Eastern Time) on May 7, 2019 (Press release, Mannkind, APR 30, 2019, View Source [SID1234535465]).

Presenting from the Company will be its Chief Executive Officer, Michael Castagna and Chief Financial Officer, Steven Binder.

To participate in the live call by telephone, please dial (800) 289-0438 or (323) 794-2423 and use the participant passcode: 6329706. Those interested in listening to the conference call live via the Internet may do so by visiting the Company’s website at View Source under News & Events.

A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (844) 512-2921 or (412) 317-6671 and use the participant passcode: 6329706. A replay will also be available on MannKind’s website for 14 days.

OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019

On April 30, 2019 OPKO Health, Inc. (NASDAQ: OPK) reported its operating and financial results for the three months ended March 31, 2019, as well as provide guidance on expected revenues and operating expenses for the second quarter 2019, after the close of the U.S. financial markets on Tuesday, May 7, 2019 (Press release, Opko Health, APR 30, 2019, View Source [SID1234535464]).

OPKO’s senior management will provide a business update and discuss its financial results in a live conference call and audio webcast beginning at 4:30 p.m. Eastern time on Tuesday, May 7, 2019.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO’s senior management will provide a business update and discuss results in greater detail in a conference call and live audio webcast at 4:30 p.m. Eastern time on Tuesday, May 7, 2019. The conference call dial-in and webcast information is as follows:

DOMESTIC DIAL-IN: 866-634-2258
INTERNATIONAL DIAL-IN: 330-863-3454
PASSCODE: 1547027
WEBCAST: View Source
For those unable to participate in the live conference call or webcast, a replay will be available beginning approximately two hours after the close of the conference call. To access the replay, dial 855-859-2056 or 404-537-3406. The replay passcode is 1547027. The replay can be accessed for a period of time on OPKO’s website at View Source

Audentes Therapeutics to Release First Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, May 7, 2019

On April 30, 2019 Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, reported that it will host a conference call and webcast to report its first quarter 2019 financial results and provide a corporate update on Tuesday, May 7, 2019 (Press release, Audentes Therapeutics, APR 30, 2019, View Source [SID1234535463]).

The conference call will be held at 4:30 pm EDT. To access a live webcast of the conference call, please visit the Events & Presentations page within the Investor + Media section of the Audentes website at www.audentestx.com. Alternatively, please call (833) 659-8620 (U.S.) or (409) 767-9247 (international) and dial the conference ID# 6839198 to access the call.

A replay of the live webcast will be available on the Audentes website for approximately 30 days.

Genomic Health to Announce First Quarter 2019 Financial Results and Host Conference Call on Tuesday, May 7, 2019

On April 30, 2019 Genomic Health, Inc. (NASDAQ: GHDX) reported that the company will host a conference call and webcast on Tuesday, May 7 at 4:30 p.m. Eastern Time to discuss its first quarter 2019 financial results (Press release, Genomic Health, APR 30, 2019, View Source [SID1234535462]). The call and webcast will follow the release of the first quarter financial results after market close.

Conference Call Details
To access the live conference call on May 7 at 4:30 p.m. Eastern Time via phone, please dial (877) 303-7208 from the United States and Canada, or +1 (224) 357-2389 internationally. The conference call ID is 6535029. Please dial in approximately 10 minutes prior to the start of the call.

To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company’s web site at View Source Please connect to the web site at least 15 minutes prior to the presentation to allow for any software download that may be necessary.